Table 1 Patient characteristics and outcome
Pt | Gender | Clinical features | Laboratory markers at time of liver biopsy | Chest X-ray findings | Abdominal (and other) ultrasound findings | Duration of anti-TB therapy pre-liver biopsy (Days) | Duration of anti-TB therapy post-liver biopsy (Months) | Outcome at 1 year follow-up | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
H | J | S | CD4 cells/μl | TBil μmol/l | ALT u/l | ALP u/l | GGT u/l | ALB g/l | |||||||
1 | F | Y | N | N | 43 | 15 | 49 | 2339 | 1268 | 17 | Normal | ALN | 7a | 13 | R |
2 | F | Y | Y | N | 55 | 40 | 56 | 106 | 194 | 17 | Normal | H, ALN | 9 | 9 | R |
3 | M | N | N | N | 17 | 7 | 98 | 1035 | 275 | 23 | Extensive paratracheal and hilar shadowing, active TB, nodular shadowing | Normal | 140 | 5 | D |
4 | F | Y | Y | Y | 6 | 35 | 32 | 654 | 547 | 15 | Consolidation with breakdown in RUZ, cavitation | Findings NR | 50 | 7 | R |
5 | M | N | N | Y | 175 | 31 | 110 | 280 | 194 | 14 | Large paratracheal lymph nodes | Findings NR | Post-biopsy | 9 | R |
6 | F | N | N | N | 96 | 44 | 94 | 1110 | 994 | 16 | Reticulonodular shadowing, paratracheal lymph nodes | Findings NR | 6 | NR | R |
7 | F | Y | N | N | 56 | 3 | 35 | 1088 | 873 | 15 | Extensive reticulonodular shadows, miliary pattern | Findings NR | 21a | <1 | D |
8 | M | Y | N | N | 157 | 16 | 37 | 467 | 401 | 17 | Left PE | H, ALN | 175 | 9 | MDR-TB |
9 | M | Y | N | Y | 117b | 14 | 26c | 387 | 112 | 18 | Diaphragm pushed up. Other findings NR | H, Sp | 13 | NR | R |
10 | F | Y | N | Y | 34 | 14 | 42 | 323 | 451 | 21 | Nodular infiltrates in right lower zone | H, Sp | 5 | 9 | R |
11 | F | Y | N | N | 123b | 42 | 116 | 415 | 326 | 17 | Miliary pattern | Normal | 0 | NR | R |
12 | F | Y | N | N | 15b | 6 | 11 | 186 | 78 | 15 | Findings NR | H, ALN | Post-biopsy | 1 | D |
13 | F | Y | Y | N | 163 | 21 | 30c | 448 | 278 | 17 | LUZ consolidation, opacities in RUZ, RMZ and LMZ. Hilar lymph nodes | H, ALN, Sp, ascites, (PE, PCE) | 39 | 8 | D |
14 | F | Y | Y | N | 20 | 21 | 95 | 2226 | 1257 | 26 | Fibrosis of right upper lobe, nodular infiltrates in both lower zones | ALN | 121a | 9 | R |
15 | F | Y | Y | N | 42d | 24 | 33 | 541 | 599 | 24 | Small bilateral PE | H | 219 | >8 | XDR-TB |
16 | F | Y | Y | N | 17d | 65 | 57 | 1050 | 443 | 21 | Right upper lobe infiltrates | ALN, Sp | 121a | 9 | R |
17 | F | Y | Y | N | 49 | 26 | 28 | 321 | 86 | 11 | Bilateral opacification, miliary TB | ALN, Sp | 103a | 6 | D |
18 | F | Y | N | Y | 45 | 6 | 41 | 463 | 1075 | 20 | Reticular infiltrates in RUZ and LUZ | H, ALN | 50 | 6 | R |
19 | M | Y | N | Y | 59 | 32 | 55 | 297 | 321 | 20 | Mediastinal widening, no infiltrates | H, ALN, Sp (PE, PCE) | 97 | 3 | D |
20 | M | Y | N | N | 37 | 13 | 163 | 326 | 460 | 28 | Findings NR | Not done | 81a | >8 | R |